Easing the Transition to Automated Insulin Delivery for Non-Traditional Users

Easing the Transition to Automated Insulin Delivery for Non-Traditional Users | Recording

Recorded Webinar

In this webinar, we will discuss who can benefit from these systems; dispel myths about the ‘ideal candidate’; and describe strategies for supporting and optimizing AID use.

Overview

Automated Insulin Delivery systems have become the standard of care for Type 1 Diabetes.

In this webinar, we will discuss who can benefit from these systems; dispel myths about the ‘ideal candidate’; and describe strategies for supporting and optimizing AID use.

Moderator

Laya Ekhlaspour, MD

Assistant Professor of Pediatrics, Division of Endocrinology

University of California, San Francisco

Speakers

Cari Berget, RN, MPH, CDCES

Instructor, Barbara Davis Center for Diabetes, University of Colorado

Manager, PANTHER Research Team

Director, PANTHER Program

Molly L. Tanenbaum, PhD

Clinical Assistant Professor

Department of Medicine, Division of Endocrinology, Gerontology, & Metabolism

Department of Pediatrics, Division of Endocrinology and Diabetes (by courtesy)

Stanford University School of Medicine

Learning Objectives

1. Understand the evidence base around who can benefit from the AID use.
2. Identify nontraditional bolus strategies for those who do not count carbs.
3. Describe psychosocial support for AID onboarding and ongoing use.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account